Genesis Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Parsippany, NJ and active since 1999.
Genesis Pharmaceuticals Inc was established in 1999, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Leonard Mazur at the company’s single location by writing to 8 Campus Drive # 2, Parsippany, New Jersey NJ 07054 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Genesis Pharmaceuticals Inc |
Contact Person: | Leonard Mazur |
Address: | 8 Campus Drive # 2, Parsippany, New Jersey 07054 |
Website Address: | glytone-usa.com |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Founded: | 1999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Genesis Pharmaceuticals Inc was started in 1999 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Leonard Mazur for inquiries that concern Genesis Pharmaceuticals Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Genesis Pharmaceuticals Inc can be found at the coordinates 40.843835,-74.451445 as well as the street address 8 Campus Drive # 2 in Parsippany, New Jersey 07054.
For its online presence, you may visit Genesis Pharmaceuticals Inc’s website at glytone-usa.com and engage with its social media outlets through on Twitter and on Facebook.